AR122557A2 - MODIFIED OLIGONUCLEOTIDE - Google Patents

MODIFIED OLIGONUCLEOTIDE

Info

Publication number
AR122557A2
AR122557A2 ARP210101546A ARP210101546A AR122557A2 AR 122557 A2 AR122557 A2 AR 122557A2 AR P210101546 A ARP210101546 A AR P210101546A AR P210101546 A ARP210101546 A AR P210101546A AR 122557 A2 AR122557 A2 AR 122557A2
Authority
AR
Argentina
Prior art keywords
modified oligonucleotide
seq
salt
formula
chemical structure
Prior art date
Application number
ARP210101546A
Other languages
Spanish (es)
Inventor
Frank Rigo
Original Assignee
Ionis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ionis Pharmaceuticals Inc filed Critical Ionis Pharmaceuticals Inc
Publication of AR122557A2 publication Critical patent/AR122557A2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

Un oligonucleótido modificado que tiene la siguiente estructura química: de fórmula (1) (SEQ ID Nº 49), o una sal del mismo.A modified oligonucleotide having the following chemical structure: of formula (1) (SEQ ID No. 49), or a salt thereof.

ARP210101546A 2015-04-16 2021-06-07 MODIFIED OLIGONUCLEOTIDE AR122557A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562148691P 2015-04-16 2015-04-16

Publications (1)

Publication Number Publication Date
AR122557A2 true AR122557A2 (en) 2022-09-21

Family

ID=59487559

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP160101046A AR104297A1 (en) 2015-04-16 2016-04-15 COMPOSITIONS TO MODULATE THE EXPRESSION OF C9ORF72
ARP210101546A AR122557A2 (en) 2015-04-16 2021-06-07 MODIFIED OLIGONUCLEOTIDE

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP160101046A AR104297A1 (en) 2015-04-16 2016-04-15 COMPOSITIONS TO MODULATE THE EXPRESSION OF C9ORF72

Country Status (1)

Country Link
AR (2) AR104297A1 (en)

Also Published As

Publication number Publication date
AR104297A1 (en) 2017-07-12

Similar Documents

Publication Publication Date Title
MX2018011139A (en) Acrylic acid, and methods of producing thereof.
MX2018006148A (en) Inhibitors of cxcr2.
UY36315A (en) NEW INTEGRINE ANTIGONIST COMPOUNDS avß6.
SG10201808940WA (en) Nox inhibitor and nfкb inhibitor containing methoxyflavone
EA201790266A1 (en) INDOLS FOR USE IN INFECTIONS CAUSED BY THE FLU VIRUS
CY1121602T1 (en) COMPOSITION OF KOPANLISIMPI AND ITS DIHYDROCHLORATE
TR201818825T4 (en) LNCRNAS FOR THE TREATMENT AND DIAGNOSIS OF CARDIAC HYPERTROPHY
CL2019001381A1 (en) Method for the treatment of focal segmental glomerulosclerosis.
FR3041540B1 (en) SELF-MOUSING CLEANING COMPOSITION FOR RINSING, CONTAINING IVERMECTIN.
EA201692508A1 (en) POLYENE MACROLIDE DERIVATIVE
DK3402782T3 (en) 8-AMINO-2-OXO-1,3-DIAZA-SPIRO- [4.5] -DECANDERIVATER
MX2019010950A (en) Phenalene-1-one-containing photosensitizer composition, phenalene-1-one compound and the use thereof.
CL2017000151A1 (en) Pyridone derivatives
GB2548017A (en) A clip
ES2722109T3 (en) Modified thymine polynucleotide oligomers, and methods
CL2016001745A1 (en) -3'-methyl-abscisic acid (s) and esters thereof
PL403939A1 (en) DNA aptamers recognizing the histidine tag and their use
JP2015043197A5 (en)
AR122557A2 (en) MODIFIED OLIGONUCLEOTIDE
MX2019001202A (en) Compound inhibiting formation of c-myc/max/dna complex.
IT201700094491A1 (en) Reactor.
MX2018005689A (en) Intrathecal delivery of nucleic acid sequences encoding abcd1 for treatment of adrenomyeloneuropathy.
JP2016045189A5 (en)
WO2016054519A8 (en) Methods and systems for carrying out a ph-influenced chemical and/or biological reaction
FRIDA FRID